Standout Papers
- Angiogenesis: regulators and clinical applications (2001)
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture (2014)
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment (2020)
- Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern (2022)
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses (2018)
Immediate Impact
20 by Nobel laureates 7 from Science/Nature 83 standout
Citing Papers
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants
2022 Standout
Works of Johan Neyts being referenced
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
2022 Standout
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Johan Neyts | 9835 | 6341 | 6442 | 672 | 24.0k | |
| Michaël Otto | 19292 | 4585 | 22690 | 374 | 38.5k | |
| Richard Kühn | 11582 | 3834 | 6741 | 495 | 25.9k | |
| Giorgio Palù | 5178 | 6401 | 5979 | 532 | 18.6k | |
| Raymond F. Schinazi | 10753 | 6904 | 7185 | 661 | 25.2k | |
| Jan Balzarini | 14419 | 8162 | 10681 | 869 | 32.9k | |
| Shibo Jiang | 19134 | 4214 | 6770 | 493 | 27.9k | |
| Dominique Schols | 7422 | 3809 | 7001 | 542 | 23.4k | |
| Pei‐Yong Shi | 14932 | 2887 | 4632 | 374 | 24.2k | |
| Bruno Canard | 8825 | 2341 | 5317 | 264 | 16.1k | |
| Naoki Yamamoto | 5444 | 5069 | 9738 | 735 | 30.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...